{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:49:17Z","timestamp":1791920957385,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002894","name":"AAAAI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019212","name":"American Academy of Allergy, Asthma and Immunology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","award":["KL2TR003099"],"award-info":[{"award-number":["KL2TR003099"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaip.2024.02.019","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T06:23:32Z","timestamp":1709101412000},"page":"1109-1119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Non\u2013IgE-Mediated Immediate Drug-Induced Hypersensitivity Reactions"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4110-7221","authenticated-orcid":false,"given":"Santiago","family":"Alvarez-Arango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Sabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.02.019_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-012-1376-5","article-title":"Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority","volume":"69","author":"Ribeiro-Vaz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2024.02.019_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009593","article-title":"High-throughput framework for genetic analyses of adverse drug reactions using electronic health records","volume":"17","author":"Zheng","year":"2021","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaip.2024.02.019_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2022.09.004","article-title":"MRGPRX2 in drug allergy: what we know and what we do not know","volume":"151","author":"Kolkhir","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaci.2018.09.022","article-title":"Controversies in drug allergy: in\u00a0vitro testing","volume":"143","author":"Mayorga","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib8","first-page":"425","article-title":"Drug desensitization","volume":"24","author":"Solensky","year":"2004","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.jaip.2024.02.019_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaip.2015.12.019","article-title":"Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies","volume":"4","author":"Sloane","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib10","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2021.02.012","article-title":"Non\u2013IgE-mediated anaphylaxis","volume":"147","author":"Cianferoni","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1398-9995.2008.01924.x","article-title":"Update on the evaluation of hypersensitivity reactions to betalactams","volume":"64","author":"Blanca","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1398-9995.2008.01693.x","article-title":"Important questions in allergy: 1\u2013drug allergy\/hypersensitivity","volume":"63","author":"Demoly","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib14","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1067\/mai.2002.122214","article-title":"Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions","volume":"109","author":"Adkinson","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/all.13848","article-title":"The challenge of de-labeling penicillin allergy","volume":"75","author":"Stone","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/antibiotics11111543","article-title":"Meta-analysis of clinical trials comparing cefazolin to cefuroxime, ceftriaxone, and cefamandole for surgical site infection prevention","volume":"11","author":"Ahmed","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jaip.2024.02.019_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.anai.2017.11.022","article-title":"Clinical and economic burden of hospitalizations with registration of penicillin allergy","volume":"120","author":"Sousa-Pinto","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib19","first-page":"27","article-title":"Pathophysiology of immunologic and nonimmunologic systemic reactions including anaphylaxis","volume":"42","author":"Fowler","year":"2022","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.jaip.2024.02.019_bib20","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib21","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jaci.2016.02.015","article-title":"Human IgE-independent systemic anaphylaxis","volume":"137","author":"Finkelman","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2012-07-442541","article-title":"The high-affinity human IgG receptor Fc\u03b3RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy","volume":"121","author":"Mancardi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.02.019_bib24","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.4049\/jimmunol.164.8.4332","article-title":"Expression of a functional high-affinity IgG receptor, Fc\u03b3RI, on human mast cells: up-regulation by IFN-\u03b3","volume":"164","author":"Okayama","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0161-5890(02)00077-9","article-title":"Activation of human mast cells through the high affinity IgG receptor","volume":"38","author":"Tkaczyk","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2003.11.007","article-title":"Activation of human mast cells by aggregated IgG through Fc\u03b3RI: additive effects of C3a","volume":"110","author":"Woolhiser","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib27","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U","article-title":"IgG-dependent activation of human mast cells following up-regulation of Fc\u03b3RI by IFN-\u03b3","volume":"31","author":"Woolhiser","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib28","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.02.019_bib29","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U","article-title":"IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma","volume":"31","author":"Woolhiser","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib30","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2011-07-367334","article-title":"Human Fc\u03b3RIIA induces anaphylactic and allergic reactions","volume":"119","author":"Jonsson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.02.019_bib31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaci.2016.06.058","article-title":"Mechanisms of anaphylaxis in human low-affinity IgG receptor locus knock-in mice","volume":"139","author":"Gillis","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib32","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1172\/JCI45232","article-title":"Mouse and human neutrophils induce anaphylaxis","volume":"121","author":"Jonsson","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.02.019_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2008.02.008","article-title":"Basophils play a pivotal role in immunoglobulin-G\u2013mediated but not immunoglobulin-E\u2013mediated systemic anaphylaxis","volume":"28","author":"Tsujimura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2024.02.019_bib34","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1073\/pnas.1720553115","article-title":"Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration","volume":"115","author":"Cloutier","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2024.02.019_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan5997","article-title":"Platelets expressing IgG receptor Fc\u03b3RIIA\/CD32A determine the severity of experimental anaphylaxis","volume":"3","author":"Beutier","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI25575","article-title":"IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in\u00a0vivo through both antigen interception and Fc gamma RIIb cross-linking","volume":"116","author":"Strait","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.02.019_bib37","article-title":"Tumor-associated neutrophils and macrophages exacerbate antidrug IgG-mediated anaphylactic reaction against an immune checkpoint inhibitor","volume":"10","author":"Arai","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jaip.2024.02.019_bib38","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4049\/jimmunol.2200234","article-title":"IgG Subclass-dependent pulmonary antigen retention during acute IgG-dependent systemic anaphylaxis in mice","volume":"209","author":"Todorova","year":"2022","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis","volume":"11","author":"Jonsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2024.02.019_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3324\/haematol.2018.199448","article-title":"Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors Fc\u03b5RI and Fc\u03b3RIII","volume":"104","author":"Rathod","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2024.02.019_bib41","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/leu.2012.102","article-title":"Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2024.02.019_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676354","article-title":"MRGPRX2 and adverse drug reactions","volume":"12","author":"McNeil","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell\u2013specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.02.019_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1026304","article-title":"Mas-related G protein\u2013coupled receptor MRGPRX2 in human basophils: expression and functional studies","volume":"13","author":"Toscano","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cells10051033","article-title":"Unlocking the non\u2013IgE-mediated pseudo-allergic reaction puzzle with Mas-related G-protein\u2013coupled receptor member X2 (MRGPRX2)","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.02.019_bib46","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/all.14213","article-title":"The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: expression and function","volume":"75","author":"Wedi","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jdermsci.2016.05.006","article-title":"Angiogenic peptide (AG)-30\/5C activates human keratinocytes to produce cytokines\/chemokines and to migrate and proliferate via MrgX receptors","volume":"83","author":"Kiatsurayanon","year":"2016","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2024.02.019_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fncel.2019.00299","article-title":"Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function","volume":"13","author":"Varricchi","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jaip.2024.02.019_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tips.2023.02.002","article-title":"The structure, function, and pharmacology of MRGPRs","volume":"44","author":"Cao","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaip.2024.02.019_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108259","article-title":"MAS-related G protein\u2013coupled receptors X (MRGPRX): orphan GPCRs with potential as targets for future drugs","volume":"238","author":"Al Hamwi","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaip.2024.02.019_bib51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-021-04077-y","article-title":"Structure, function and pharmacology of human itch receptor complexes","volume":"600","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.02.019_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","article-title":"Structure, function and pharmacology of human itch GPCRs","volume":"600","author":"Cao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2024.02.019_bib53","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein\u2013coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib54","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.3390\/ijms20215247","article-title":"Identification of gain and loss of function missense variants in MRGPRX2\u2019s transmembrane and intracellular domains for mast cell activation by substance P","volume":"20","author":"Chompunud Na Ayudhya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2024.02.019_bib55","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2018.09.034","article-title":"Rocuronium hypersensitivity: does off-target occupation of the MRGPRX2 receptor play a role?","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/ACI.0b013e3283489bc3","article-title":"Hypersensitivity reactions to quinolones","volume":"11","author":"Blanca-L\u00f3pez","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaip.2018.09.008","article-title":"Controversies in allergy: is skin testing required prior to drug challenges?","volume":"7","author":"Macy","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12016-021-08919-5","article-title":"Road less traveled: drug hypersensitivity to fluoroquinolones, vancomycin, tetracyclines, and macrolides","volume":"62","author":"Zhu","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib59","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaip.2020.09.017","article-title":"Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic","volume":"9","author":"Krantz","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4049\/jimmunol.1701793","article-title":"Naturally occurring missense MRGPRX2 variants display loss of function phenotype for mast cell degranulation in response to substance P, hemokinin-1, human \u03b2-defensin-3, and icatibant","volume":"201","author":"Alkanfari","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib61","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1172\/JCI85538","article-title":"Different activation signals induce distinct mast cell degranulation strategies","volume":"126","author":"Gaudenzio","year":"2016","journal-title":"J\u00a0Clin Iinvest"},{"key":"10.1016\/j.jaip.2024.02.019_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaip.2022.12.014","article-title":"Allergenic and Mas-related G protein\u2013coupled receptor X2-activating properties of drugs: resolving the two","volume":"11","author":"Sabato","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2014.05.004","article-title":"Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria","volume":"134","author":"Fujisawa","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib64","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jid.2020.06.030","article-title":"MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria","volume":"141","author":"Shtessel","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2024.02.019_bib65","article-title":"Expression of MRGPRX2 in skin mast cells of patients with maculopapular cutaneous mastocytosis","volume":"9","author":"Deepak","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Practi"},{"key":"10.1016\/j.jaip.2024.02.019_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930945","article-title":"The number of MRGPRX2-expressing cells is increased in skin lesions of patients with indolent systemic mastocytosis, but is not linked to symptom severity","volume":"13","author":"Pyatilova","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835618","article-title":"Overexpression of Fc\u03b5RI on bone marrow mast cells, but not MRGPRX2, in clonal mast cell disorders with wasp venom anaphylaxis","volume":"13","author":"Elst","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib68","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.36.6.1204","article-title":"Absence of \"red man syndrome\" in patients being treated with vancomycin or high-dose teicoplanin","volume":"36","author":"Rybak","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2024.02.019_bib69","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.bja.2020.10.006","article-title":"Immunoglobulin E cross-linking or MRGPRX2 activation: clinical insights from rocuronium hypersensitivity","volume":"126","author":"Ebo","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.02.019_bib70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000446182","article-title":"Non\u2013IgE-dependent hypersensitivity to rocuronium reversed by sugammadex: report of three cases and hypothesis on the underlying mechanism","volume":"169","author":"Spoerl","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668962","article-title":"Novel insights on MRGPRX2-mediated hypersensitivity to neuromuscular blocking agents and fluoroquinolones","volume":"12","author":"Elst","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib72","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1016\/j.bja.2020.05.046","article-title":"Association between mutated Mas-related G protein\u2013coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis","volume":"125","author":"Suzuki","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.02.019_bib73","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/j.bja.2020.08.035","article-title":"Association between mutated Mas-related G protein\u2013coupled receptor-X2 and rocuronium-induced intraoperative anaphylaxis. Comment on Br J Anaesth 2020;125:e446\u20138","volume":"125","author":"Elst","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.02.019_bib74","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/cells10010156","article-title":"MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants","volume":"10","author":"Chompunud Na Ayudhya","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.02.019_bib75","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11882-017-0742-x","article-title":"Update on quinolone allergy: a complementary note","volume":"17","author":"Van Gasse","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.02.019_bib76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jaip.2024.02.019_bib77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","article-title":"Mast cell\u2013mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent","volume":"70","author":"Liu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaip.2024.02.019_bib78","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1038\/s41598-022-10549-6","article-title":"Determination of key residues in MRGPRX2 to enhance pseudo-allergic reactions induced by fluoroquinolones","volume":"12","author":"Hamamura-Yasuno","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.02.019_bib79","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMp2031891","article-title":"Vancomycin infusion reaction\u2014moving beyond \u201cred man syndrome.\u201d","volume":"384","author":"Alvarez-Arango","year":"2021","journal-title":"N\u00a0Engl J Medi"},{"key":"10.1016\/j.jaip.2024.02.019_bib80","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaip.2020.09.027","article-title":"Vancomycin hypersensitivity reactions documented in electronic health records","volume":"9","author":"Alvarez-Arango","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2024.02.019_bib82","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaip.2022.11.001","article-title":"Patient characteristics associated with reactions to MRGPRX2-activating drugs in an electronic health record\u2013linked biobank","volume":"11","author":"Foer","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib83","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00204-022-03402-2","article-title":"Opioid toxicity: histamine, hypersensitivity, and MRGPRX2","volume":"97","author":"Baldo","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jaip.2024.02.019_bib84","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/jphp.13009","article-title":"Relationship between MRGPRX2 and pethidine hydrochloride\u2013 or fentanyl citrate\u2013induced LAD2 cell degranulation","volume":"70","author":"Liu","year":"2018","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jaip.2024.02.019_bib85","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib86","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor\u2013induced upper airway angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"Jo Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib87","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0625.2011.01410.x","article-title":"Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H1-antihistamines","volume":"21","author":"Maurer","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaip.2024.02.019_bib88","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/all.15847","article-title":"Meglumine gadoterate induces immunoglobulin-independent human mast cell activation via MRGPRX2","volume":"78","author":"Ruiz de Azc\u00e1rate","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111323","article-title":"MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol","volume":"137","author":"Yuan","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaip.2024.02.019_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.12.655","article-title":"A\u00a0group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice","author":"Wolf","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib91","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/cells10112906","article-title":"Therapeutic potential of MRGPRX2 inhibitors on mast cells","volume":"10","author":"Ogasawara","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaip.2024.02.019_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89362","article-title":"Dual action of neurokinin-1 antagonists on Mas-related GPCRs","volume":"1","author":"Azimi","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2024.02.019_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173104","article-title":"A\u00a0novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell\u2013mediated anaphylaxis","volume":"878","author":"Suzuki","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaip.2024.02.019_bib94","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2022.12.805","article-title":"Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction","volume":"151","author":"Kumar","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib95","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/JLB.2AB1018-405R","article-title":"Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cells","volume":"106","author":"Ogasawara","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2024.02.019_bib96","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/all.15270","article-title":"Fc\u03b5RI- and MRGPRX2-evoked acute degranulation responses are fully additive in human skin mast cells","volume":"77","author":"Babina","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688930","article-title":"Antibody or anybody? Considering the role of MRGPRX2 in acute drug-induced anaphylaxis and as a therapeutic target","volume":"12","author":"Mackay","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib98","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1111\/bcp.15845","article-title":"MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms, and distinguishing MRGPRX2- and IgE\/FcepsilonRI-mediated events","volume":"89","author":"Baldo","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2024.02.019_bib99","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/all.13236","article-title":"Immediate moxifloxacin hypersensitivity: is there more than currently meets the eye?","volume":"72","author":"Van Gasse","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bja.2023.05.002","article-title":"Suspected perioperative anaphylaxis: are we making the correct diagnosis?","volume":"131","author":"Ebo","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2024.02.019_bib101","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/cea.14129","article-title":"Mast cell activation test: a new asset in the investigation of the chlorhexidine cross-sensitization profile","volume":"52","author":"Ebo","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib102","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1111\/all.14497","article-title":"IgE-mediated chlorhexidine allergy\u2014cross-reactivity with other biguanide disinfectants","volume":"75","author":"Mueller-Wirth","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib103","article-title":"The passively sensitized mast cell activation test is a reliable diagnostic for chlorhexidine allergy","volume":"9","author":"Elst","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0750-7658(05)81016-0","article-title":"The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia","volume":"12","author":"Fisher","year":"1993","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jaip.2024.02.019_bib105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2222.2008.03171.x","article-title":"On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective","volume":"39","author":"Baldo","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib106","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0076-6879(03)73010-9","article-title":"The interaction of liposomes with the complement system: in\u00a0vitro and in\u00a0vivo assays","volume":"373","author":"Szebeni","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jaip.2024.02.019_bib107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11882-023-01064-3","article-title":"Recent updates in understanding NSAID hypersensitivity","volume":"23","author":"Minaldi","year":"2023","journal-title":"CurrAllergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.02.019_bib108","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib109","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.jaip.2022.09.020","article-title":"A\u00a0review of adverse reactions to biologics used in allergy-immunology practice","volume":"10","author":"Chow","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.02.019_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-016-0598-5","article-title":"Mast cells and anaphylaxis","volume":"16","author":"Lieberman","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.02.019_bib111","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0091-6749(81)90134-2","article-title":"Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses","volume":"68","author":"Kaliner","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib112","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41594-018-0068-y","article-title":"Structural basis for signal recognition and transduction by platelet-activating-factor receptor","volume":"25","author":"Cao","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jaip.2024.02.019_bib113","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.147.2.660","article-title":"Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells","volume":"147","author":"Triggiani","year":"1991","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.02.019_bib115","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jaci.2015.04.019","article-title":"Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis","volume":"135","author":"Gill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256168","article-title":"Clinical significance of plasma PAF acetylhydrolase activity measurements as a biomarker of anaphylaxis: cross-sectional study","volume":"16","author":"Piwowarek","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.02.019_bib117","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/all.13752","article-title":"Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: an observational study","volume":"74","author":"Vitte","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib118","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1213\/ANE.0000000000002656","article-title":"Improvement of the elevated tryptase criterion to discriminate IgE- from non\u2013IgE-mediated allergic reactions","volume":"127","author":"Gastaminza","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2024.02.019_bib119","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00000542-199809000-00010","article-title":"Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions","volume":"89","author":"Renz","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaip.2024.02.019_bib120","first-page":"65","article-title":"Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics","volume":"28","author":"Gueant","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib121","first-page":"289","article-title":"A\u00a0role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase","volume":"286","author":"He","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2024.02.019_bib122","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/cea.14110","article-title":"Tryptase release does not discriminate between IgE- and MRGPRX2-mediated activation in human mast cells","volume":"52","author":"Elst","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib123","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib124","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/all.14747","article-title":"Basophil activation test: mechanisms and considerations for use in clinical trials and clinical practice","volume":"76","author":"Santos","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2016.10.003","article-title":"Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity","volume":"118","author":"Mawhirt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.02.019_bib126","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/cea.13850","article-title":"Vancomycin immediate skin responses in vancomycin-na\u00efve subjects","volume":"51","author":"Alvarez-Arango","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib127","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2500\/aap.2021.42.200091","article-title":"Skin testing and drug challenge in the evaluation of drug hypersensitivity reactions","volume":"42","author":"Wolfson","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2024.02.019_bib128","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/all.14252","article-title":"Surface expression of MRGPRX2 on resting basophils: an area of controversy","volume":"75","author":"Sabato","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.02.019_bib129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2008.11.004","article-title":"Peanuts can contribute to anaphylactic shock by activating complement","volume":"123","author":"Khodoun","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T02:02:00Z","timestamp":1724464920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213219824001934"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.02.019","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2013IgE-Mediated Immediate Drug-Induced Hypersensitivity Reactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}